Methoxypregnenolone
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2019 (NCT03870776)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Mineralocorticoid receptorAGONIST
NR3C2 agonist
- Glucocorticoid receptorAGONIST
NR3C1 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04157114 | Phase 2 | Jan 6, 2020 | Mapreg, National Institute on Alcohol Abuse and Alcoholism (NIAAA), Scripps |
| NCT03870776 | Phase 2 | Apr 1, 2019 | Mapreg |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Mapreg | For profit | 2 | 1 | 1 | 2019 |
| National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Government | 1 | 0 | 1 | 2020 |
| Scripps | Academic/Hospital | 1 | 1 | 1 | 2020 |
3 organizations
Page 1 / 1